Clinical Potassium Pilot Study

NACompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

April 29, 2020

Primary Completion Date

September 9, 2020

Study Completion Date

September 9, 2020

Conditions
Hyperkalemia
Interventions
DEVICE

GEPII

Saliva probes (K+Sa) will be measured using genetically encoded potassium ion indicators (GEPIIs)

DEVICE

Ion-selective electrodes

Plasma potassium levels (K+Pl) will be measured using standard ion-selective electrodes.

Trial Locations (1)

Unknown

Medical University of Graz, Graz

All Listed Sponsors
collaborator

NGFI Next Generation Fluorescence Imaging GmbH

UNKNOWN

lead

Medical University of Graz

OTHER

NCT04251468 - Clinical Potassium Pilot Study | Biotech Hunter | Biotech Hunter